One of the most underappreciated shifts in global capital markets today is the return of industrial policy as a core determinant of long-term equity outcomes. In a world shaped by geopolitical fragmentation, weaponised supply chains, and strategic technology rivalry, governments are no longer neutral referees. They are active balance-sheet participants. Yet not all state interventions are created equal.

Recent U.S. industrial policy initiatives highlight two sharply contrasting approaches to state support, exemplified by MP Materials and Intel Corporation. Both operate in sectors deemed critical to national security—rare earths and semiconductors. Both have received explicit government backing. But the design of that backing, the allocation of risk, and the linkage between public capital and real economic output differ profoundly.

For long-term retail investors—particularly those focused on quality, capital efficiency, and earnings durability—this contrast offers a masterclass in how industrial policy can either compound value or merely postpone accountability.

MP Materials: Demand Anchoring as Intelligent Industrial Policy

The U.S. government’s support for MP Materials represents a textbook example of outcome-linked intervention. Rather than indiscriminately injecting capital, policymakers have structured support around two principles that matter most in commodity-linked businesses: price stability and demand certainty.

A Ten-Year Price Floor That Rewrites the Risk Equation

At the heart of the policy framework is a ten-year price floor of USD 110 per kilogram for neodymium and praseodymium (NdPr). These rare earth elements are essential inputs for permanent magnets used in electric vehicles, wind turbines, defense systems, robotics, and advanced electronics—high-growth end markets aligned with secular megatrends.

If global NdPr prices fall below this threshold, the U.S. government compensates MP Materials for the difference. This effectively transfers commodity price volatility from the company’s income statement to the sovereign balance sheet.

From an investor’s perspective, this is transformational:

  • Revenue visibility improves materially
  • Downside risk compresses
  • Cash-flow volatility—traditionally the Achilles’ heel of mining businesses—reduces sharply

This is not a subsidy designed to keep an uncompetitive producer alive. It is a risk-sharing contract that incentivises domestic supply formation while preserving operational discipline.

Guaranteed Offtake: The Ultimate Capital De-Risking Tool

Even more critical is the Department of Defense’s commitment to purchase the entire output of MP Materials’ second magnet manufacturing facility, which is still in the pre-construction phase. This forward offtake agreement eliminates the two biggest risks in industrial expansion:

  1. Who will buy the output?
  2. At what price?

By answering both questions in advance, the government enables MP Materials to invest with confidence, shorten payback cycles, and accelerate time-to-scale. In Saurabh Mukherjea’s investing framework, this is the equivalent of converting a cyclical commodity business into a quasi-annuity.

The policy logic is elegant: public money is released only when supply is delivered. Capacity creation, utilisation, and strategic security are tightly linked.

Intel: Capital Support Without Demand Creation

The U.S. government’s engagement with Intel tells a very different story—one rooted in capital provision rather than market creation.

CHIPS Act Support: Balance-Sheet Engineering, Not Business De-Risking

Under the CHIPS and Science Act, Intel was initially awarded roughly USD 12 billion in grants and subsidies. However, only about USD 3 billion ultimately flowed as direct grants. The remaining USD 9 billion was restructured—under the Trump Administration—into a direct cash investment accompanied by warrants.

These warrants grant the U.S. government potential equity upside should Intel divest more than 50% of its manufacturing assets in the future.

While this improves Intel’s liquidity and strengthens its balance sheet, it leaves a critical question unanswered: Who will actually use Intel’s fabs?

Unlike MP Materials, there is:

  • No guaranteed offtake
  • No minimum utilisation clause
  • No long-term procurement commitment from the state

The policy implicitly assumes that Intel’s primary bottleneck is capital availability, not competitiveness, execution consistency, or customer trust.

Market Confidence and the Utilisation Problem

Semiconductor manufacturing is not just capital-intensive; it is trust-intensive. Customers do not shift advanced-node production lightly. Yield consistency, process maturity, ecosystem integration, and execution track record matter far more than headline capex numbers.

Private Capital Without Operating Commitments

Intel has attracted interest and financial participation from ecosystem players, including NVIDIA and SoftBank Group. However, crucially, these relationships stop short of binding manufacturing volume commitments at Intel Foundry Services.

The hesitation is understandable. Intel’s recent history—including quality and yield issues associated with its 13th- and 14th-generation Core CPUs—has dented confidence. In foundry economics, perception lags reality, and trust once lost takes years to rebuild.

Without guaranteed utilisation, new fabs risk becoming under-absorbed assets—capital-heavy structures generating suboptimal returns on invested capital (ROIC).

Why MP Materials’ Model Is Superior for Shareholders

From a capital allocation lens, MP Materials’ support framework aligns almost perfectly with long-term shareholder interests:

  • Public capital is conditional on output
  • Risk is shifted away from minority shareholders
  • Execution incentives remain intact
  • Strategic objectives are met without distorting pricing signals

Intel’s framework, by contrast, socialises downside risk while leaving upside dependent on management execution in an intensely competitive global industry.

This distinction matters enormously for retail investors seeking predictable compounding rather than speculative turnarounds.

The Missing Piece: Will the U.S. Force Demand for Intel?

The unresolved question in U.S. semiconductor policy is whether the government will eventually move beyond passive capital support and adopt a more interventionist stance on demand creation.

One theoretical option would be to incentivise—or mandate—domestic fab utilisation by U.S. technology champions such as Apple, Qualcomm, or Broadcom.

Such a move would fundamentally alter Intel’s risk profile by:

  • Anchoring utilisation
  • Accelerating learning curves
  • Restoring ecosystem confidence

However, this approach raises political, economic, and legal challenges. Forced demand risks inefficiency, higher end-product costs, and pushback from globally integrated supply chains.

Capital Alone Does Not Create Competitiveness

The lesson from these two case studies is simple but profound: capital is a necessary condition for industrial revival, but not a sufficient one.

MP Materials demonstrates that when public policy:

  • Anchors demand
  • Stabilises pricing
  • Rewards execution

…it can catalyse private investment and accelerate strategic capacity creation.

Intel’s experience suggests that when policy stops at balance-sheet support, it risks becoming an expensive bet on managerial turnaround rather than a structured pathway to competitiveness.

Conclusion: Two Levers, Two Outcomes

For investors navigating the intersection of geopolitics, industrial policy, and equity markets, the contrast between MP Materials and Intel is instructive.

One model uses the state to guarantee outcomes.
The other uses the state to absorb risk.

Over the long term, equity value is created not by the size of government cheques, but by how intelligently they are designed. As U.S. industrial policy evolves, the critical determinant of success will be whether policymakers prioritise demand certainty and utilisation over mere capital deployment.

For retail investors with a long-term horizon, understanding this distinction may be the difference between owning future compounders and funding expensive experiments.